Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/SL65.0155> ?p ?o }
Showing triples 1 to 79 of
79
with 100 triples per page.
- SL65.0155 abstract "SL65.0155 is a selective 5-HT4 receptor partial agonist (Ki = 0.6 nM; IA = 40-50% (relative to 5-HT)). It potently enhances cognition, learning, and memory, and also possesses antidepressant effects. SL65.0155 was in phase II clinical trials around 2004-2006 for the treatment of memory deficits and dementia but no new information has surfaced since and it appears to have been abandoned.".
- SL65.0155 atcPrefix "none".
- SL65.0155 casNumber "?".
- SL65.0155 iupacName "5-(5-amino-6-chloro-2,3-dihydro-1,4-benzodioxin-8-yl)-3-(1-phenethyl-4-piperidyl)-1,3,4-oxadiazol-2-one hydrochloride".
- SL65.0155 pubchem "9805718".
- SL65.0155 thumbnail SL650155-structure.png?width=300.
- SL65.0155 wikiPageID "26482753".
- SL65.0155 wikiPageLength "5483".
- SL65.0155 wikiPageOutDegree "19".
- SL65.0155 wikiPageRevisionID "679039564".
- SL65.0155 wikiPageWikiLink 5-HT4_receptor.
- SL65.0155 wikiPageWikiLink Amnesia.
- SL65.0155 wikiPageWikiLink Antidepressant.
- SL65.0155 wikiPageWikiLink Binding_selectivity.
- SL65.0155 wikiPageWikiLink Category:Benzodioxins.
- SL65.0155 wikiPageWikiLink Category:Carbamates.
- SL65.0155 wikiPageWikiLink Category:Chloroarenes.
- SL65.0155 wikiPageWikiLink Category:Lactams.
- SL65.0155 wikiPageWikiLink Category:Oxadiazoles.
- SL65.0155 wikiPageWikiLink Category:Piperidines.
- SL65.0155 wikiPageWikiLink Clinical_trial.
- SL65.0155 wikiPageWikiLink Cognition.
- SL65.0155 wikiPageWikiLink Dementia.
- SL65.0155 wikiPageWikiLink Learning.
- SL65.0155 wikiPageWikiLink Memory.
- SL65.0155 wikiPageWikiLink Partial_agonist.
- SL65.0155 wikiPageWikiLink RS-67,333.
- SL65.0155 wikiPageWikiLink Serotonin.
- SL65.0155 wikiPageWikiLinkText "SL65.0155".
- SL65.0155 atcPrefix "none".
- SL65.0155 c "23".
- SL65.0155 casNumber "?".
- SL65.0155 chemspiderid "7981478".
- SL65.0155 cl "2".
- SL65.0155 h "26".
- SL65.0155 iupacName "5".
- SL65.0155 molecularWeight "493.38".
- SL65.0155 n "4".
- SL65.0155 o "4".
- SL65.0155 pubchem "9805718".
- SL65.0155 smiles "Cl.O=C1O/Cc5cccN".
- SL65.0155 width "150".
- SL65.0155 wikiPageUsesTemplate Template:Antidementia.
- SL65.0155 wikiPageUsesTemplate Template:Antidepressants.
- SL65.0155 wikiPageUsesTemplate Template:Drugbox.
- SL65.0155 wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- SL65.0155 wikiPageUsesTemplate Template:Nootropics.
- SL65.0155 wikiPageUsesTemplate Template:Reflist.
- SL65.0155 wikiPageUsesTemplate Template:Serotonergics.
- SL65.0155 subject Category:Benzodioxins.
- SL65.0155 subject Category:Carbamates.
- SL65.0155 subject Category:Chloroarenes.
- SL65.0155 subject Category:Lactams.
- SL65.0155 subject Category:Oxadiazoles.
- SL65.0155 subject Category:Piperidines.
- SL65.0155 hypernym HT.
- SL65.0155 type ChemicalSubstance.
- SL65.0155 type Drug.
- SL65.0155 type Amide.
- SL65.0155 type Carbamate.
- SL65.0155 type Drug.
- SL65.0155 type Ester.
- SL65.0155 type Heterocycle.
- SL65.0155 type Lactam.
- SL65.0155 type Organohalide.
- SL65.0155 type Organohalide.
- SL65.0155 type ChemicalObject.
- SL65.0155 type Thing.
- SL65.0155 type Q8386.
- SL65.0155 comment "SL65.0155 is a selective 5-HT4 receptor partial agonist (Ki = 0.6 nM; IA = 40-50% (relative to 5-HT)). It potently enhances cognition, learning, and memory, and also possesses antidepressant effects. SL65.0155 was in phase II clinical trials around 2004-2006 for the treatment of memory deficits and dementia but no new information has surfaced since and it appears to have been abandoned.".
- SL65.0155 label "SL65.0155".
- SL65.0155 sameAs Q75892.
- SL65.0155 sameAs m.0bbznfv.
- SL65.0155 sameAs SL65.0155.
- SL65.0155 sameAs SL65.0155.
- SL65.0155 sameAs Q75892.
- SL65.0155 wasDerivedFrom SL65.0155?oldid=679039564.
- SL65.0155 depiction SL650155-structure.png.
- SL65.0155 isPrimaryTopicOf SL65.0155.